Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Siri Laura Feruglio

20 publications found

Original articles

Hagberg G, Skytøen ER, Nakstad I, O' Sullivan K, Koht J, Johansen TKB, Feruglio SL, Frøyshov S (2024)
Iatrogenic botulism
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0625, PubMed 38349108

Amato E, Hyllestad S, Heradstveit P, Langlete P, Moen LV, Rohringer A, Pires J, Baz Lomba JA, Bragstad K, Feruglio SL, Aavitsland P, Madslien EH (2023)
Evaluation of the pilot wastewater surveillance for SARS-CoV-2 in Norway, June 2022 - March 2023
BMC Public Health, 23 (1), 1714
DOI 10.1186/s12889-023-16627-2, PubMed 37667223

Bruvoll M, Leirvik MJ, Holte K, Feruglio SL, Kanestrøm A (2022)
[Brucellosis with acute arthritis and positive blood culture]
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0293, PubMed 36416659

Jalali N, Brustad HK, Frigessi A, MacDonald EA, Meijerink H, Feruglio SL, Nygård KM, Rø G, Madslien EH, de Blasio BF (2022)
Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants
Nat Commun, 13 (1), 5706
DOI 10.1038/s41467-022-33233-9, PubMed 36175424

Tscherne A, Mantel E, Boskani T, Budniak S, Elschner M, Fasanella A, Feruglio SL, Galante D, Giske CG, Grunow R, Henczko J, Hinz C, Iwaniak W, Jacob D, Kedrak-Jablonska A, Jensen VK, Johansen TB, Kahlmeter G, Manzulli V, Matuschek E, Melzer F, Nuncio MS, Papaparaskevas J, Pelerito A, Solheim M et al. (2022)
Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method
Microorganisms, 10 (7)
DOI 10.3390/microorganisms10071470, PubMed 35889189

Brandal LT, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U, Feruglio S, Bragstad K, Hungnes O, Ødeskaug LE, Hagen F, Hanch-Hansen KE, Lind A, Watle SV, Taxt AM, Johansen M, Vold L, Aavitsland P, Nygård K, Madslien EH (2021)
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
Euro Surveill, 26 (50)
DOI 10.2807/1560-7917.ES.2021.26.50.2101147, PubMed 34915975

Meijerink H, Mauroy C, Johansen MK, Braaten SM, Lunde CUS, Arnesen TM, Feruglio SL, Nygård K, Madslien EH (2021)
The First GAEN-Based COVID-19 Contact Tracing App in Norway Identifies 80% of Close Contacts in "Real Life" Scenarios
Front Digit Health, 3, 731098
DOI 10.3389/fdgth.2021.731098, PubMed 34870268

Veneti L, Seppälä E, Larsdatter Storm M, Valcarcel Salamanca B, Alnes Buanes E, Aasand N, Naseer U, Bragstad K, Hungnes O, Bøås H, Kvåle R, Golestani K, Feruglio S, Vold L, Nygård K, Whittaker R (2021)
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021
PLoS One, 16 (10), e0258513
DOI 10.1371/journal.pone.0258513, PubMed 34634066

Gossner CM, Mailles A, Aznar I, Dimina E, Echevarría JE, Feruglio SL, Lange H, Maraglino FP, Parodi P, Perevoscikovs J, Van der Stede Y, Bakonyi T (2020)
Prevention of human rabies: a challenge for the European Union and the European Economic Area
Euro Surveill, 25 (38)
DOI 10.2807/1560-7917.ES.2020.25.38.2000158, PubMed 32975184

Wolff C, Lange H, Feruglio S, Vold L, MacDonald E (2019)
Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017
BMC Public Health, 19 (1), 1624
DOI 10.1186/s12889-019-7981-9, PubMed 31795996

Bårnes GK, Gudina EK, Berhane M, Abdissa A, Tesfaw G, Abebe G, Feruglio SL, Caugant DA, Jørgensen HJ (2018)
New molecular tools for meningitis diagnostics in Ethiopia - a necessary step towards improving antimicrobial prescription
BMC Infect Dis, 18 (1), 684
DOI 10.1186/s12879-018-3589-4, PubMed 30572843

Johansen TB, Scheffer L, Jensen VK, Bohlin J, Feruglio SL (2018)
Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective
Sci Rep, 8 (1), 8538
DOI 10.1038/s41598-018-26906-3, PubMed 29867163

Feruglio SL, Kvale D, Dyrhol-Riise AM (2017)
T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
Scand J Immunol, 85 (2), 138-146
DOI 10.1111/sji.12511, PubMed 27862137

Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM (2015)
Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
Clin Exp Immunol, 179 (3), 454-65
DOI 10.1111/cei.12468, PubMed 25313008

Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM (2015)
IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
J Infect, 70 (4), 381-91
DOI 10.1016/j.jinf.2014.12.019, PubMed 25597826

Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
PLoS One, 8 (7), e69896
DOI 10.1371/journal.pone.0069896, PubMed 23875007

Nygård K, Brantsaeter A, Feruglio S, Ravn J, Dotevall L, Hasle G, Myrvang B (2006)
[Histoplasmosis among travellers to Central America]
Tidsskr Nor Laegeforen, 126 (21), 2838-42
PubMed 17086244

Røttingen JA, Feruglio SL, Aasland OG, Fugelli P (2002)
[Local and global environmental medicine--assessment by Norwegian physicians]
Tidsskr Nor Laegeforen, 122 (13), 1285-9
PubMed 12098923

Mørch K, Feruglio SL, Ormaasen V, Bruun JN (2002)
[Severe falciparum malaria treated with exchange transfusion]
Tidsskr Nor Laegeforen, 122 (10), 999-1001
PubMed 12082710